F. Roufosse

Most-cited papers

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
P. Valent, A. Klion, H. Horny, F. Roufosse +14 more
2012Journal of Allergy and Clinical Immunology732 citations Open access
Semantic Scholar
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
F. Roufosse, J. Kahn, M. Rothenberg, A. Wardlaw +8 more
2020Journal of Allergy and Clinical Immunology187 citations Open access
Semantic Scholar
Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma
F. Roufosse
2018Frontiers in Medicine178 citations Open access
Semantic Scholar
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes
F. Roufosse, J. Kahn, G. Gleich, L. Schwartz +11 more
2012Journal of Allergy and Clinical Immunology170 citations Open access
Semantic Scholar
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field
P. Valent, G. Gleich, A. Reiter, F. Roufosse +16 more
2012Expert Review of Hematology159 citations Open access
Semantic Scholar
Proposed Refined Diagnostic Criteria and Classification of Eosinophil Disorders and Related Syndromes
P. Valent, A. Klion, F. Roufosse, D. Simon +19 more
2022Allergy. European Journal of Allergy and Clinical Immunology157 citations Open access
Semantic Scholar
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
M. Wechsler, P. Nair, B. Terrier, Bastian Walz +12 more
2024New England Journal of Medicine139 citations Open access
Semantic Scholar
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
F. Roufosse, A. de Lavareille, L. Schandené, E. Cogan +7 more
2010Journal of Allergy and Clinical Immunology106 citations Open access
Semantic Scholar
Eosinophils and eosinophilic immune dysfunction in health and disease
D. Jackson, P. Akuthota, F. Roufosse
2022European Respiratory Review98 citations Open access
Semantic Scholar
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies
E. Jacobsen, D. Jackson, E. Heffler, S. Mathur +5 more
2021Annual Review of Immunology98 citations Open access
Semantic Scholar
Novel targeted therapies for eosinophilic disorders
M. Wechsler, P. Fulkerson, B. Bochner, G. Gauvreau +15 more
2012Journal of Allergy and Clinical Immunology97 citations Open access
Semantic Scholar
From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases
I. Pavord, E. Bel, A. Bourdin, Robert H Chan +9 more
2021Allergy. European Journal of Allergy and Clinical Immunology86 citations Open access
Semantic Scholar
Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils
K. Buchheit, D. Shaw, G. Chupp, Lauri Lehtimaki +12 more
2024Allergy. European Journal of Allergy and Clinical Immunology81 citations Open access
Semantic Scholar
Clinical management of the hypereosinophilic syndromes
E. Cogan, F. Roufosse
2012Expert Review of Hematology58 citations Open access
Semantic Scholar
What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?
J. Catherine, F. Roufosse
2021Seminars in Immunopathology48 citations Open access
Semantic Scholar
Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.
M. Wechsler, B. Hellmich, M. Cid, D. Jayne +3 more
2023Journal of Allergy and Clinical Immunology46 citations Open access
Semantic Scholar
Hypereosinophilic syndrome: considerations for the cardiologist
A. Bondue, C. Carpentier, F. Roufosse
2021Heart46 citations Open access
Semantic Scholar
Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia
E. Brenard, C. Pilette, C. Dahlqvist, B. Colinet +3 more
2020Lung45 citations Open access
Semantic Scholar
Lymphoproliferative disorders associated with hypereosinophilia.
F. Roufosse, S. Garaud, L. D. de Leval
2012Seminars in hematology (Print)43 citations
Semantic Scholar
Cells from a vanished twin as a source of microchimerism 40 years later in a male with a scleroderma-like condition.
L. M. de Bellefon, P. Heiman, Sami B. Kanaan, Doua F. Azzouz +5 more
2010Chimerism43 citations Open access
Semantic Scholar
Eosinophilia Associated With CD3−CD4+ T Cells: Characterization and Outcome of a Single-Center Cohort of 26 Patients
C. Carpentier, S. Verbanck, L. Schandené, P. Heimann +3 more
2020Frontiers in Immunology40 citations Open access
Semantic Scholar
Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD)
P. Khoury, P. Akuthota, S. Ackerman, J. Arron +23 more
2018Journal of Leukocyte Biology40 citations Open access
Semantic Scholar
HES and EGPA: Two Sides of the Same Coin
P. Khoury, P. Akuthota, N. Kwon, J. Steinfeld +1 more
2023Mayo Clinic proceedings39 citations Open access
Semantic Scholar
Clinical reviews in allergy and immunology
D. Y. Leung, Dennis K. Ledford, M. Wechsler, P. Fulkerson +17 more
201236 citations
Semantic Scholar
Safety and efficacy of mepolizumab in hypereosinophilic syndrome: an open-label extension study.
G. Gleich, F. Roufosse, G. Chupp, S. Faguer +5 more
2021Journal of Allergy and Clinical Immunology: In Practice35 citations Open access
Semantic Scholar
FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders
S. Garaud, F. Roufosse, Pushpamali De Silva, C. Gu-Trantien +8 more
2017European Journal of Immunology33 citations Open access
Semantic Scholar
Management of Hypereosinophilic Syndromes.
F. Roufosse
2015Immunology and allergy clinics of North America32 citations
Semantic Scholar
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes
Michael M Chen, F. Roufosse, Sa A. Wang, S. Verstovsek +20 more
2022Journal of Allergy and Clinical Immunology: In Practice31 citations Open access
Semantic Scholar
ICON: Eosinophil Disorders
P. Valent, A. Klion, L. Rosenwasser, M. Arock +17 more
2012The World Allergy Organization Journal31 citations Open access
Semantic Scholar
CD3-CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited.
C. Carpentier, L. Schandené, Laurent Dewispelaere, P. Heimann +2 more
2021Journal of Allergy and Clinical Immunology: In Practice24 citations Open access
Semantic Scholar
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis.
P. Merkel, P. Nair, N. Khalidi, B. Terrier +16 more
2025Annals of the Rheumatic Diseases18 citations Open access
Semantic Scholar
Mepolizumab reduces hypereosinophilic syndrome flares irrespective of blood eosinophil count and IL-5.
M. Rothenberg, F. Roufosse, S. Faguer, G. Gleich +4 more
2022Journal of Allergy and Clinical Immunology: In Practice18 citations Open access
Semantic Scholar
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases
M. Strobel, Debbie Alves, F. Roufosse, Z. Antoun +3 more
2022Journal of Patient Experience15 citations Open access
Semantic Scholar
Lymphocytic variant hypereosinophilic syndrome progressing to angioimmunoblastic T-cell lymphoma
F. Roufosse, L. D. de Leval, H. V. van Krieken, M. van Deuren
2015Leukemia and Lymphoma15 citations
Semantic Scholar
Improving Care in Eosinophil-Associated Diseases: A Charter
D. Jackson, P. Akuthota, Rebeca Andradas, A. Bredenoord +11 more
2022Advances in Therapy13 citations Open access
Semantic Scholar
Methylprednisolone-Induced Lymphocytosis in Patients with Immune-Mediated Inflammatory Disorders.
L. Bromberg, F. Roufosse, O. Pradier, C. Delporte +3 more
2016American Journal of Medicine13 citations
Semantic Scholar
Eosinophils affect functions of in vitro-activated human CD3-CD4+ T cells
Issam Harfi, L. Schandené, S. Dremier, F. Roufosse
2013Journal of Translational Medicine12 citations Open access
Semantic Scholar
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
F. Roufosse, J. Butterfield, J. Steinfeld, J. Bentley +3 more
2023Frontiers in Medicine10 citations Open access
Semantic Scholar
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial
P. Ogbogu, F. Roufosse, Praveen Akuthota, Piotr Kuna +18 more
2026Nature Medicine8 citations Open access
Semantic Scholar
The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis
P. Nair, Bernhard Hellmich, A. Bourdin, D. Jayne +11 more
2025Arthritis & Rheumatology8 citations Open access
Semantic Scholar
Mepolizumab in patients with lymphoid variant hypereosinophilic syndrome: a multi-center prospective study.
Julien Catherine, S. Karimi, Laurent Dewispelaere, C. Lelubre +2 more
2025Journal of Allergy and Clinical Immunology6 citations Open access
Semantic Scholar
Oral Corticosteroid Use for the Treatment of Chronic Eosinophilic Disease: A Patient’s and His Physician’s Experience
Mitchell Silva, F. Roufosse
2019Advances in Therapy6 citations Open access
Semantic Scholar
Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association
F. Roufosse, P. Heimann, F. Lambert, P. Sidon +3 more
2016Respiration5 citations
Semantic Scholar
Eosinophils in Human Disease
E. Gelfand, D. Simon, H. Simon, Alex Thomas +26 more
2012Eosinophils in Health and Disease5 citations
Semantic Scholar
Biologic Therapy in Rare Eosinophil-Associated Disorders: Remaining Questions and Translational Research Opportunities.
P. Khoury, F. Roufosse, Fei-Li Kuang, Steven J. Ackerman +9 more
2024Journal of Leukocyte Biology4 citations Open access
Semantic Scholar
Clinical value at baseline and follow-up of myeloperoxidase-antibodies in ANCA-associated vasculitis
Gabriel Bossan, F. Roufosse, F. Vandergheynst, Julie Smet +2 more
2025Frontiers in Immunology3 citations Open access
Semantic Scholar
BENRALIZUMAB FOR PATIENTS WITH HYPEREOSINOPHILIC SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL (NATRON)
P. Ogbogu, F. Roufosse, P. Akuthota, P. Lacwik +18 more
2025Annals of Allergy, Asthma & Immunology3 citations
Semantic Scholar
Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use program.
Gauthier Coussement, Julien Catherine, F. Roufosse
2024Journal of Leukocyte Biology3 citations
Semantic Scholar
Clonal eosinophil and mast cell diseases: different in the same way?
V. de Wilde, F. Roufosse, O. Hermine
2016Expert Review of Hematology3 citations Open access
Semantic Scholar
Peripheral T-cell lymphoma developing after diagnosis of lymphocytic variant hypereosinophilic syndrome: misdiagnosed lymphoma or natural disease progression?
F. Roufosse
2014Oral surgery, oral medicine, oral pathology and oral radiology3 citations Open access
Semantic Scholar